DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

Nektar Therapeutics

NASDAQ: NKTR



company name or ticker

Narrower-than-Expected Q3 Loss at Nektar - Analyst Blog

Why Nektar Therapeutics Inc. Shares Soared

Nektar shares throttle analysts estimates for the third quarter. Is this a one-time event or can you expect great things from Nektar moving forward?

Nektar Therapeutics' CEO Discusses Q3 2013 Results - Earnings Call Transcript

Short Interest In Nektar Therapeutics Falls 12.5%

Should Investors Have A Sweet Tooth For Nektar?

Pipeline Update at Nektar - Analyst Blog

Oversold Conditions For Nektar Therapeutics (NKTR)

Nektar Therapeutics' CEO Hosts Investor and Analyst R&D Day Conference (Transcript)

Nektar Reports on Advancements with Clinical Pipeline and Introduces New Preclinical Candidates at I

Nektar Reports on Advancements with Clinical Pipeline and Introduces New Preclinical Candidates at Investor and Analyst R&D Day

Pipeline Progresses at AstraZeneca - Analyst Blog

See More Articles...